The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
Cerebroprotection after administration of glutamate receptor antagonists has been well documented. The present study is intended to determine whether the non-competitive alpha-amino-3-hydroxy-methyl-4-isoxazolyl-propionic acid (AMPA) receptor antagonist talampanel, known as antiepileptic drug, has n...
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2005
|
| Sorozat: | BRAIN RESEARCH BULLETIN
66 No. 1 |
| Tárgyszavak: | |
| doi: | 10.1016/j.brainresbull.2005.03.012 |
| mtmt: | 2802858 |
| Online Access: | https://publikacio.ppke.hu/2378 |